GoodRx Holdings, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by GoodRx Holdings, Inc. on March 17, 2025, reporting events occurring on March 16, 2025. The filing details a significant share repurchase transaction executed under the Company's existing Repurchase Program.
Key Financial Metrics and Transaction Details
- Transaction Type: Repurchase of Class A common stock from three institutional investors.
- Total Shares Repurchased: 20,000,000 shares (3,000,000 from Spectrum; 10,000,000 from Francisco Partners; 7,000,000 from Idea Men).
- Repurchase Price: $4.20 per share.
- Market Price Reference: $4.42 per share (closing price on the last trading day prior to the Effective Date).
- Discount: The repurchase price represents a discount to the prior closing share price.
- Program Capacity: The transaction is part of a $450.0 million Repurchase Program.
- Remaining Authority: Approximately $198.3 million is expected to remain available after this transaction (inclusive of direct costs, exclusive of excise taxes).
- Expected Closing Date: On or about March 21, 2025.
Material Changes and Lock-Up Provisions
In connection with the repurchase, the selling shareholders (Spectrum, Francisco Partners, and Idea Men) and their affiliates have agreed to a lock-up period. They are prohibited from selling, transferring, disposing of, or entering into hedging transactions involving the Company's securities until the completion of the second full trading day following the public release of earnings data for the quarter ended March 31, 2025.
Guidance, Outlook, and Risks
The filing contains forward-looking statements regarding the anticipated closing of the repurchase and the remaining amount available under the Repurchase Program. The Company cautions that these statements are not guarantees and are subject to risks and uncertainties, including those detailed in the "Risk Factors" section of the Annual Report on Form 10-K for the fiscal year ended December 31, 2024. The filing does not provide specific operational guidance or financial projections beyond the transaction details.
Investor Verification Checklist
- Verify the final closing date of the March 2025 Repurchase (expected March 21, 2025).
- Confirm the actual cash outflow once excise taxes are calculated and paid.
- Monitor the Company's earnings release for the quarter ended March 31, 2025, to determine the exact end date of the shareholder lock-up period.
- Review the updated remaining balance of the $450.0 million Repurchase Program in subsequent filings.